Taipei Medical University (TMU) Health announced that its healthcare system has fully adopted Inventec Corporation‘s (TPE：2356) “SmartMed Infusion System”, becoming the first in Taiwan to implement a fully connected smart infusion system across. It includes Taipei Medical University Hospital, Wan Fang Hospital, Shuang Ho Hospital, and Hsin Kuo Min Hospital, totaling 1,080 smart infusion pumps. SmartMed Infusion System enables real-time monitoring to ensure patient safety and significantly reduces the nursing workload by minimizing the need to manage infusion interruptions, setting a new milestone in smart infusion field in Taiwan.

TMU Chairman Ray-Jade Chen stated that the TMU Health achieved full integration of HIS 3.0 this year across its four hospitals, incorporating generative AI (GenAI) as part of daily operations. The "Digital, Precision, Regenerative" model includes digital pathology, genetic testing, and cell therapy, which are now foundational to clinical care. The system-wide adoption of SmartMed Infusion System is not only a crucial step in enhancing infusion safety but also a major milestone in TMU Health’s advancement toward smart healthcare. With a focus on patient safety, TMU Health also employs GenAI-driven innovations and integrates digital and physical resources to enhance medical information systems and equipment, establishing a strong foundation for a smart ward and marking significant progress toward a smart hospital.

TMU President Mai-Szu Wu emphasized the "One Campus" concept leading TMU Health’s future vision. The collaboration with Inventec in implementing the SmartMed Infusion System uses advanced digital technology, IoT, and automation to optimize the healthcare environment. This initiative is a concrete realization of smart ward characteristics, focusing on improving patient safety and comfort while reducing the workload on healthcare professionals, ultimately moving toward efficient, precise medical care.

Inventec Vice President for Medical Electronics Business Ching-An Tseng highlighted that the SmartMed Infusion System includes self-developed SmartMed infusion pump, SmartNet System Software, and various kinds of infusion sets co-developed with Niddleless Corporation. The implementation of SmartMed Infusion System by TMU reflects Inventec Group’s strengthened role in the medical device business. This MIT (Made in Taiwan) smart infusion system is expected to challenge the dominance of foreign brands in infusion business.

The SmartMed Infusion System offers four major highlights:

1. Automated Infusion Parameter Setting and Error Prevention: When nurses scan correct patient and medicine barcodes, SmartMed system will automatically download doctor’s order infusion parameters to the pump and record log in the system to minimize manual entry errors, ensuring precision and safety in infusion procedure.

2. Real-Time Monitoring and Alert System: Through the SmartNet System Software, nurses can monitor the status of all infusion pumps on a central dashboard or mobile device. Alerts are sent instantly if abnormalities occur, enabling timely responses to prevent risks.

3. Closed-Loop Smart Medication System: SmartMed Infusion System is highly integrated with the hospital’s information system, allowing all processes from prescription to infusion pump operation to be traced, preventing omissions or errors and enhancing patient safety.

4. Enhanced Nurse Medication Management: SmartMed Infusion System can reduce the need for manual operations by nurses, and improve work efficiency and reinforce nurses’ role in monitoring and confirming medication administration accuracy, to ensure patient safety.

According to the U.S. Institute for Safe Medication Practices (ISMP), conventional smart infusion pumps are often associated with errors due to operational complexity. Taiwan’s Ministry of Health and Welfare emphasizes the importance of high-alert medication management and flow control in its 2024-2025 patient safety goals. In the first three months following implementation of SmartMed Infusion System (August to October 2024), TMU Health’s database recorded 136 potential near misses intercepted by SmartMed Infusion System across four hospitals, with a near miss prevention rate of 0.44% (136 incidents out of 30,562 patient days). Compared to the international medication error rate of 2.3%-17.7% for conventional smart infusion pumps, SmartMed Infusion System shows superior accuracy and preventive capabilities, significantly enhancing patient safety. Additionally, SmartMed Infusion System reduce the need for nurses to manually match medications or adjust infusion volumes, saving approximately 4 minutes per use, totaling 795 hours saved monthly, enhancing efficiency and reducing operational near miss incidents.

The collaboration between TMU Health and Inventec not only highlights the potential of integrating healthcare and technology but also aims to improve medical quality and patient safety through the development of smart wards. With extensive clinical experience in smart medical applications and ongoing innovation in medical information systems, TMU Health and Inventec anticipate further advancements in medical services, aiming to offer efficient, convenient care. This collaboration is expected to encourage more hospitals to adopt Taiwan-made smart medical devices, and may promote Taiwan’s leading healthcare technology and service models to Southeast Asia, benefiting more people.

而此MIT（Made in Taiwan）台灣研發製造的智慧輸液有四大亮點：

1. 自動化輸液參數設定與醫療疏失阻斷： 當護理師掃描病人及藥品條碼後，系統會自動將醫師開立的輸液參數下載至輸液幫浦，同步記錄在系統中，減少人工輸入錯誤的風險，確保每次輸液操作的精準度與安全性。

2. 實時監控與異常提醒： 透過連線系統，護理師可在中央控制台或移動設備上即時監控所有輸液幫浦的狀態，若出現異常或中斷，系統將立即發出警報，讓護理師能迅速反應，避免醫療風險。

3. 閉環式智慧給藥系統：與醫院的資訊系統高度整合，從醫囑開立、輸液幫浦運作到輸液紀錄回傳，所有過程均可追溯，有效防止遺漏或錯誤，進一步保障病人安全。

4. 護理師的用藥把關： 系統的自動化設計減少了護理師手動操作需求，提升了工作效率，同時強化護理師在給藥過程中的監控與確認角色，提高給藥精確性、處理輸液異常的即時性，確保了每位病人的給藥安全。

根據美國用藥安全作業協會（ISMP）報告，傳統靜脈輸液幫浦在操作中常因複雜性而導致用藥錯誤。衛生福利部113-114年度病人安全工作目標中強調加強高警訊藥品的管理及流速控制的重要性。臺北醫學大學醫院資訊團隊與思邁智慧輸液系統進行系統整合，可同步比對病人、醫囑、藥品，自動設置輸液參數，提升護理師工作效率並確保病人輸液安全。北醫大醫療體系導入3個月內(2024年8月-10月)期間從系統後台資料庫可發現輸液藥物在未給到病人身上前，系統成功阻斷可能發生的跡近錯失（near miss）四院總計136件，錯誤阻斷率為0.44%(136件除以總使用人日數30,562)。換言之，一旦幫浦沒有成功阻斷，就可能會有0.44%的給藥錯誤發生率，相較於國外文獻提及使用一般型智慧輸液幫浦系統給藥錯誤發生率2.3%-17.7%不等，本系統展現了更高的精準度與預防能力，在病人安全保障上具有顯著優勢。另一方面，智慧輸液幫浦可免除忙碌護理師之人工藥物比對、輸液量調整等繁瑣操作，每人次使用可節省約4分鐘操作時間，平均每個月共可節省了795小時，顯著提升護理師工作效率並降低操作錯誤風險。

北醫體系與英業達集團的合作，不僅展示了醫療與科技結合的潛力，還期望透過智慧病房的發展，進一步提升醫療品質與病人安全。北醫體系具備豐富的智慧醫療臨床應用經驗，以及持續創新醫療資訊系統的能力，雙方期盼未來持續創新醫療服務，實現更高效、便捷的醫療照護體驗。這不僅將鼓勵更多醫院採用MIT台灣製造的智慧醫療設備，也有望將台灣領先的醫療技術和服務模式推廣至東南亞地區，展現台灣卓越的醫療實力，造福更多民眾。